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ABSTRACT 
 
The purpose of this study was to determine the effects of a high carbohydrate (HCHO) and low 
carbohydrate (LCHO) diet on the adjustment of pulmonary oxygen (O2) uptake ( 2pOV& ) and 
muscle deoxygenation ([HHb]) during transitions to heavy intensity exercise. Young, healthy, 
male subjects aged (24+/-3) underwent a four day LCHO diet followed immediately by a four 
day HCHO diet, with each diet preceded by a glycogen depletion protocol. This protocol was 
designed to alter pyruvate dehydrogenase (PDH) activity. Subjects completed three step 
transitions to a work rate corresponding to 35% of the difference between their lactate threshold 
and 2pOV& peak for each condition. On day three of the diets gas exchange measurements were 
collected using mass spectrometry and [HHb] measures were recorded using near-infrared 
spectroscopy (NIRS). On day four of the diets muscle biopsies were taken from the vastus 
lateralis muscle of the quadriceps muscle group at steady-state baseline exercise (20 W) and at 
15 s and 360 s during the transition to heavy exercise. These biopsies were frozen for later 
analysis of: PDH activation, ADP concentration, glycogen content, and phosphocreatine 
concentration. It was found that the dietary manipulation had a significant effect (p<0.05) on 
phase II 2pOV&  time constant (LCHO=41.9 s, HCHO=33.7 s) and no effect on the rate of 
adjustment of [HHb] (p>0.05). This study posits that PDH plays an important role in the 
adjustment of oxidative metabolism to exercise.  
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Chapter 1 
1 Review of the Literature  
1.1 What are VO2p kinetics? 
When transitioning from rest to exercise there is an immediate change in the energy 
requirements of the muscle cell. Not all of the energy required for this exercise can be met 
immediately through aerobic metabolism and thus anaerobic metabolism must support ATP 
requirements as the mitochondrial oxidative phosphorylation system adjusts. The assessment of 
the rate at which oxygen uptake ( 2OV& ) in the contracting skeletal muscle ( 2mOV& ) adapts in 
response to a change in metabolic demand describes 2OV&  kinetics. A slower adjustment of 
2mOV&  at exercise onset limits exercise tolerance as increased reliance on anaerobic metabolism 
generates a buildup of metabolites linked to fatigue (e.g.  lactate, inorganic phosphate (Pi), 
ADP). Thus, the consequences of ‘slow’ oxygen kinetics can be a debilitating problem in older 
and diseased populations as they are more susceptible to an early onset of fatigue when 
performing regular activities. 
Due to the ethical and practical complications that are involved in measuring 2mOV&
directly, pulmonary 2OV& ( 2pOV& ) is typically recorded. This measurement was proven to reflect 
the time course and steady-state adjustments of O2 utilization in the active muscle by Grassi et al. 
(23). Recent evidence from Krustrup et al. (40) shows that 2pOV&  reflects 2mOV&  in the moderate 
and heavy intensity domain. In this experiment 2mOV&  was measured by the direct Fick technique 
and 2pOV&  was measured through indirect calorimetry. The two measurements were not 
significantly different (p>0.05). 
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Characterizing the 2OV&  response 
The 2pOV&  response to a step change in exercise intensity is commonly broken down into 
three phases. Phase I is described as the cardiodynamic phase, it reflects the time it takes for the 
blood that was present in the muscle at the onset of exercise to travel to the lungs (42) and any 
increase in 2OV&  in this phase is due to increased pulmonary blood flow (2). Phase II is termed 
the “fundamental” phase. This phase begins when deoxygenated blood from the active muscle 
returns to the lungs (2). Phase II is the most studied segment of the 2OV&  response and reflects 
the rate of adjustment of muscle O2 uptake and mitochondrial oxidative phosphorylation as a 
major source of energy production. The phase II 2pOV&  kinetics are described by the time 
constant (τ) which represents the time taken to reach 63% of the steady-state increase in the 
2pOV&  response; a 2pOV&  “steady-state” is achieved in the time equivalent of 4τ. A greater τ 2pOV&  
reflects a slower adjustment, while a smaller τ 2pOV&  is reflective of a faster rate of adjustment of 
2pOV&  and 2mOV& .  
The behavior of phase III is dependent upon exercise intensity. At an exercise intensity 
performed below the lactate threshold ( Lθˆ ) a steady state of 2pOV&  is reached. In exercise 
performed above the Lθˆ , a 2OV&  slow component is observed both in the 2pOV&  and the 2mOV&  
responses. The Lθˆ  represents a threshold above which lactate begins to accumulate in active 
muscle and blood as a result of a mismatch between the rate of pyruvate production in glycolysis 
and its subsequent oxidation in the muscle mitochondria. 
The 2OV&  slow component entails 2OV&  rising above levels that would be predicted from 
the sub-lactate threshold 2OV&  work rate (WR) relationship. It is suggested that the slow 
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component is related to the recruitment of less efficient type II muscle fibers at higher exercise 
intensities and the fatiguing of type I muscle fibers that have already been recruited (5). Type II 
muscle fibers have a higher ATP cost of force production and a higher O2 cost of ATP turnover 
(51). Heavy intensity exercise also leads to a decrease in Gibbs free energy which reduces the 
energy release from ATP hydrolysis. 
 Exercise Intensity Domains 
Exercise intensity is characterized based on common profiles of physiological and 
metabolic responses observed through a range of WRs that are separated into domains (14). Each 
exercise intensity domain presents different physiological challenges to the body. Moderate, 
heavy, and severe are the most common terms used to describe these domains. The moderate 
intensity exercise domain represents a range of work rates that can be performed below the Lθˆ . 
Within this domain, blood lactate concentration remains low (< 4 mmol/L) and, 2OV& is elevated 
(relative to rest) but maintains “steady-state” conditions (3). The heavy intensity domain 
represents a range of intensities between Lθˆ and critical power (CP), while intensities between 
CP and 2OV& max are defined as severe-intensity. Exercise within the heavy-intensity domain is 
associated with an elevated blood lactate and the appearance of a 2OV&  slow component which 
delays the achievement of a plateau in the response (27). CP corresponds to an intensity above 
which a plateau in blood lactate and 2OV&  cannot be established, and there are large disturbances 
in metabolic stability within the muscle as seen by decreases in muscle glycogen, and 
phosphocreatine, and increases in ADPfree, AMPfree, IMPfree, inorganic phosphate and H+, 
changes which are associated with reduced exercise tolerance and fatigue.  
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These exercise intensity domains are defined within the limits imposed by Lθˆ , CP, and 
2OV& max  which likely vary amongst individuals; however the response profiles within each 
domain are consistent amongst individuals. Therefore, exercise “intensities” are often prescribed 
relative to one of these defined intensity domains.  
1.2 What limits VO2 kinetics? 
There is a long standing debate in the literature as to what limits the rate of adjustment of 
2OV&  kinetics. The two main camps that have emerged include those who claim that kinetics are 
limited by convective and or diffusive O2 delivery (31) and those who claim that they are limited 
by a sluggishness of metabolic activation (19). The O2 delivery hypothesis claims that the 
metabolic response at the onset of exercise is adequate but O2 delivery is insufficient. The 
metabolic hypothesis claims that O2 is available in sufficient amounts and that the activity of rate 
limiting enzymes or the availability of substrate in the oxidative phosphorylation process is what 
limits the rate of adjustment of oxidative phosphorylation.  
O2 delivery 
Many investigations have been conducted to test whether O2 is a limiting factor in 2OV&  
kinetics. Most have focussed on blood flow manipulation. Studies using a supine vs. upright 
model have shown increased τ 2pOV&  in supine but a restoration of τ 2pOV&  once negative pressure 
is applied to restore blood flow (32). Arm exercise performed above the heart also points to an 
O2 delivery limitation (33). Exercise above the heart reduces the effects of the muscle pump and 
the driving pressure for blood flow leading to increased τ 2pOV& .  
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Restriction of O2 supply via a reduction in arterial O2 content or pressure is another 
situation where limitations are observed. Ischemia, hypoxia, and beta blockade have all been 
experimental models to explore this (17, 30). These investigations all yielded slower 2OV&  
kinetics. However, some O2 delivery limiting interventions including: blood withdrawal (10), 
hemodilution (6), and lower body positive pressure (68) have failed to report increases in τ 2OV&   
despite reductions in O2 delivery. These studies indicate that if oxygen delivery is compromised 
then kinetics may suffer but do not indicate an O2 delivery limitation under conditions of upright 
exercise in young healthy individuals.  
If O2 were a limiting factor then increasing O2 delivery should speed kinetics. 
Investigations have shown mixed results. Grassi et. al. conducted two investigations in 1998 with 
pump perfused dogs in situ in which they increased O2 delivery (21) and increased O2 driving 
pressure (20). Both of these investigations showed no difference in the adjustment of 2mOV& . 
Wilkerson et. al. conducted an investigation in humans exercising while breathing a hyperoxic 
gas mixture (67). This investigation showed no effect of hyperoxia on phase II τ 2OV&  under 
moderate, heavy, and severe exercise. Macdonald et. al. studied humans exercising in the heavy 
domain and found a speeding of phase 2 τ 2pOV&  with hyperoxia (44). These investigations point 
to a potential speeding of kinetics with increased O2 delivery only in the heavy intensity domain. 
Metabolic hypothesis 
The most convincing piece of evidence for the metabolic theory is that the kinetics of 
bulk muscle blood flow are faster than those for 2OV&  (1, 23). It is hard to imagine a slower 
process being limited by a faster one. Nitric oxide (NO) also provides compelling evidence for a 
metabolic inertia and against an O2 delivery limitation (22). NO inhibits cytochrome c oxidase 
 6 
 
activity, an enzyme in the electron transport chain, but increases blood flow. Blockade of NO 
synthase speeds 2OV&  kinetics (34, 35).  
Dichloroacetate (DCA) is a drug commonly used to activate pyruvate dehydrogenase 
(PDH) which is a rate limiting enzyme that controls the entry of carbohydrate derived substrate 
into the tricarboxylic acid cycle (TCAC). Howlett et. al. found that DCA use reduced the 
contribution of substrate level phosphorylation to energy production during exercise at 65% 2OV&
max (29). This group also saw a faster drop in intracellular PO2 and decreased glycogenolysis after 
10 minutes of exercise. These results would suggest faster activation of oxidative metabolism 
when PDH activation is increased. Investigations which measured DCA’s effect on 2OV&  kinetics 
have not shown a speeding of τ 2OV&  in the moderate (37), or heavy intensity domain (55). 
Priming models have been used as an alternative method to increase PDH activation (24). 
Priming involves the performance of a prior exercise bout before the bout that is being assessed. 
The issue with this model is that priming exercise increases PDH activation and increases muscle 
blood flow, this suggests that microvascular perfusion is elevated following priming exercise. 
This confounds the ability to determine whether metabolic inertia or O2 delivery is the limiting 
factor in the increase in oxidative phosphorylation. Spencer et. al. attempted to resolve this issue 
by adding hypoxia to the experiment (58). This negated increases in O2 delivery that are 
normally provided by priming exercise. These authors illustrated that in hypoxia after priming 
exercise speeding of kinetics was abolished. This seems to indicate that O2 delivery plays a role 
in the speeding of kinetics following priming exercise. It is important to note that PDH was not 
directly measured in this experiment and that a more severe hypoxia then that used by Spencer 
et. al. has been shown to reduce PDH activation at 1 minute following exercise onset (48). Taken 
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as a whole, the evidence suggests that 2OV&  kinetics can be limited by a number of factors 
dependent upon the individual and situation. 
1.3 Near-infrared Spectroscopy 
Near-infrared spectroscopy (NIRS) provides a measure of the amount of O2 bound to 
haemoglobin (Hb) and myoglobin (Mb) in the area of interrogation (i.e. beneath the NIRS 
probe). In this regard, the relative concentrations of bound (oxygenated) and unbound 
(deoxygenated) Hb and Mb can be used to monitor phenomena related to O2 delivery and O2 
extraction at the microvascular level. Specifically, deoxygenation ([HHb]) kinetics can be used 
as a proxy for microvascular PO2 (12). By comparing the adjustment profile of 2pOV&  with [HHb] 
the ratio of O2 extraction to O2 consumption may be discerned. This [HHb]-to- 2pOV&  ratio 
provides a sense of how O2 uptake at the cell is supported by O2 delivery (i.e. blood flow and 
arterial O2 content). If blood flow (and thus O2 delivery) is adequate, then [HHb] should match 
with VO2 in a normalized model. A ratio above 1.0 during a step change in metabolic demand 
implies under-perfusion to the active muscle that is being compensated for by increased 
fractional O2 extraction. This technique offers valuable insight into the relationship between O2 
delivery and utilization within the active muscle particularly during interventions designed to 
slow (or speed) the adjustment of O2 consumption in the active tissue. 
1.4 Overview of fat metabolism 
There is a large reserve of fat in the muscle in the form of intramuscular triglycerides 
(IMTG) and in adipose tissue stored as triglycerides (TG). This supply is favored as substrate for 
energy production when at rest and during moderate exercise. The preferential use of fat in these 
circumstances defends the limited supplies of carbohydrate in the body.  
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Intramuscular triglycerides and TG from adipocytes are broken down into glycerol and 
fatty acids by the enzyme hormone sensitive lipase (HSL). The fatty acids from adipocytes are 
transported attached to albumin through the blood and across protein transporters, such as fatty 
acid-translocase, into the muscle cell (9). Inside the muscle cell free fatty acids (FFA) are 
transported into the mitochondria for oxidation by CPT-1 (45). Once inside the mitochondria 
beta-oxidation converts fatty acids into acetyl-CoA which enters the citric acid cycle. Beta-
oxidation also produces NADH which feeds into the electron transport chain (ETC). 
Control sites for fat metabolism may include: FFA delivery to the muscle, FFA 
movement across the mitochondrial membrane, and HSL activity. At the onset of exercise blood 
flow increases which increases the delivery of FFA to the muscle. At heavy intensities of 
exercise blood flow is redistributed toward exercising muscle and away from adipose sites. This 
reduces the ability to transport FFA and therefore fat oxidation is reduced (54).  
CPT-1 is inhibited by malonyl-CoA (8). Malonyl-CoA appears in the first committed step 
in fatty acid synthesis. During exercise malonyl-CoA concentrations decrease and so does its 
inhibition of CPT-1(41). Recent research has also discovered a sensitivity of CPT-1 to drops in 
pH (8). As exercise intensity increases pH falls, this inhibits fatty acid transport during heavy 
intensity exercise.  
Hormone sensitive lipase activity responds to increases in epinephrine (EPI) and 
norepinephrine (NE) (59), insulin, dietary fat intake, and exercise intensity. At rest EPI and NE 
concentrations are low which reduces the activity of HSL. At the onset of exercise the 
concentrations of these catecholamines increase, leading to activation of HSL. Insulin inhibits fat 
metabolism by deactivating HSL (59). Insulin levels also decrease during exercise, increasing the 
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activity of HSL. After ingesting a high carbohydrate (HCHO) meal insulin levels rise, inhibiting 
HSL. Studies have shown that after a high fat diet HSL activity is increased 20-30% during 
exercise compared to a HCHO diet (62). Muscular HSL has a pH optimum of 7.0 (66). As 
exercise intensity increases pH is reduced, and muscular HSL activity falls. 
1.5 Overview of Carbohydrate metabolism 
Carbohydrates are the major substrate in exercise performed above 50-60% VO2max (54). 
Carbohydrate is stored as glycogen in the liver and muscle cells. Glycogen is broken down into 
glucose-1-phosphate units which enter glycolysis. The end product of glycolysis is pyruvate; if 
the rate of pyruvate production exceeds the rate of its oxidation it is reduced to lactate. Pyruvate 
is otherwise converted into acetyl-CoA for oxidative metabolism by PDH.  
Glucose from the blood enters the cell through GLUT4 transporters and is 
phosphorylated by hexokinase. Exercise stimulates GLUT4 movement from intracellular sites to 
the cell membrane (39). As exercise intensity increases redistribution of blood flow to exercising 
muscle increases. Greater muscle blood flow increases glucose delivery to muscle cells. 
Carbohydrate availability is crucial as glucose transport relies on facilitated diffusion. If blood 
glucose is insufficient the concentration gradient for diffusion is compromised and glucose 
transport from the blood is reduced (65). At rest, high glucose levels increase insulin levels in the 
blood which increases GLUT4 movement to the cell membrane (28). Liver glucose output 
responds to insulin and glucagon levels. As blood glucose levels decrease glucagon levels rise 
and the liver breaks down glycogen to deliver glucose to the blood. If blood glucose levels are 
high then insulin release facilitates the formation of glycogen within the liver.  
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Utilization of muscle glycogen is most rapid at exercise onset and increases with 
intensity. At exercise onset there is a rapid increase in Ca2+, EPI, AMP/ADP, and Pi. These 
metabolites all activate glycogen phosphorylase (GP). This is the rate limiting enzyme in 
glycogenolysis which commits glucosyl units cleaved from glycogen to glycolysis in the form of 
glucose-6-phosphate. Ca2+, EPI, AMP, and Pi increase with exercise intensity and stimulate 
further glycogen breakdown. At moderate intensity exercise the levels of these metabolites are 
not as high and glycogen breakdown is reduced. 
The PDH enzyme complex exists in two forms: an inactive phosphorylated form and an 
active dephosphorylated form. PDH kinase (PDK) catalyzes the phosphorylation of the E1 
enzyme on the PDH complex while PDH phosphatase (PDP) dephosphorylates it. The activities 
of PDK and PDP are determined by several allosteric regulators. Increased ratios of ATP/ADP, 
acetyl CoA/CoASH, and NADH/NAD+ activate PDK and increased pyruvate inhibits it, while 
increased sarcoplasmic Ca2+ activates PDP (60). As Ca2+, ADP, and pyruvate levels increase with 
exercise intensity PDH activity increases.  
1.6 Diet manipulation, PDH, and VO2 
Dietary manipulation has been shown to have a direct effect on PDH activity. High fat 
diets have been shown to increase reliance on fat during submaximal exercise (64), and increased 
activity of PDK (63). Peters et al. reported  a decrease in PDH activity while on a HFAT diet 
which was attributed to elevated PDK activity (50). A follow up study by the same group 
showed that these changes occur within 1 day of diet manipulation (49). With increased fat 
availability there is a decrease in GP activators Pi and AMP and PDH activators such as ADP 
(16). One theory for the reduction of these substances is due to a boost in redox potential from 
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NADH production in beta-oxidation (46). An investigation by St. Amand et. al. observed 
subjects undergoing dietary manipulation with no glycogen depletion and found that at rest PDH 
activity was subdued but during exercise at 65% 2OV& max intercellular pyruvate content was able 
to deactivate PDK and PDH activity was similar during exercise on a mixed and low CHO diet 
(61).  
1.7 Purpose 
The current study aimed to use dietary manipulation as a method of inducing changes in 
PDH activation and observe what effects it had on 2OV&  kinetics in the heavy intensity domain. 
Subjects consumed HCHO and LCHO diets preceded by a glycogen depletion protocol. Gas 
collections and NIRS data were recorded. It was hypothesized that: 1) phase 2 2pOV&  kinetics 
would be faster in the HCHO diet, 2) no effect of diet on the rate of O2 extraction would be seen 
in the NIRS data. 
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Chapter 2 
2- The effect of low and high carbohydrate diets on pulmonary oxygen uptake and muscle 
deoxygenation kinetics during exercise transitions into the heavy-intensity domain 
2.1 Introduction  
Whenever there is a change in the metabolic demand within contracting skeletal muscle, 
oxygen (O2) consumption ( 2mOV& ) increases in response to the new energy requirement. The 
adjustment of 2OV&  following a step-increase in work rate (and thus ATP turnover rate) is not 
instantaneous but increases towards a new, higher steady-state with a finite (“exponential-like”) 
time course. Due to the ethical and practical complications that are involved in measuring 2mOV&  
directly, pulmonary 2OV&  ( 2pOV& ) is typically recorded. This measurement was proven to reflect 
the time course and steady-state adjustments of O2 utilization in the active muscle by Grassi et. 
al. (23). The assessment of the speed with which 2OV&  changes to meet the metabolic 
requirements of the step change describes 2pOV&  kinetics. The kinetics of 2pOV&   (which reflect 
the rate of adjustment of oxidative phosphorylation in the active muscle mitochondria) are 
characterized by three distinct phases: the cardiodynamic phase (phase I) which is representative 
of a rapid increase in pulmonary circulation, the fundamental phase (phase II) which reflects the 
increase in 2mOV&  as it adjusts to exercise, and phase III which represents the steady-state O2 
requirement within the moderate-intensity (exercise below lactate threshold( Lθˆ )) domain or the 
2pOV&  slow component in the heavy-intensity (exercise between Lθˆ  and critical power (CP)) 
domain. The slow component is defined as 2OV&  rising above levels that would be predicted from 
the sub-lactate threshold 2OV& -work rate relationship. The phase II 2pOV&  response is described 
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by the time constant (τ 2pOV& ) which represents the time it takes to reach 63% of the steady-state 
increase in the 2pOV&  response; a 2pOV&  “steady-state” is achieved in the time equivalent of 4τ. A 
greater τ 2pOV&  reflects slower adjustment of 2pOV& , while a smaller τ 2pOV&  is reflective of a faster 
rate of adjustment of 2pOV& . 
There is a long standing debate over what limits the rate of adjustment of 2pOV&  when 
transitioning to a higher metabolic rate. Oxidative phosphorylation is described by the equation: 
NADH + H+ + 0.5O2 + 3ADP + 3Pi  3ATP + NAD+ + H2O 
The flux through this process is determined both by O2 and NADH availability which is 
dependent on oxidative substrate availability for its production. Two main hypotheses have been 
proposed to explain the slow time course of 2pOV&  relative to the change in ATP requirement:  i) 
inadequate convective and/or diffusive O2 delivery to the terminal oxidase of the mitochondrial 
Electron Transport Chain (ETC) (14) and ii) “sluggish” activation of rate limiting enzymes and 
metabolic pathways, and delivery of oxidative substrates (which result in the production of 
NADH) to the mitochondrial Tricarboxylic Acid Cycle (TCAC) and ETC (6). 
One method of investigating theory “ii” is to observe the effect of experimental activation 
of rate limiting enzymes on the rate of adjustment of 2OV& (reflected in τ 2pOV&  parameter). In this 
regard, pyruvate dehydrogenase (PDH) is a rate-limiting enzyme complex which catalyzes the 
oxidative decarboxylation of pyruvate to Acetyl CoA, NADH, H+ and CO2 and thus regulates the 
entry of carbohydrate (CHO)-derived substrate into the mitochondrial TCAC and ETC. This 
complex has received much attention as a possible contributor to the sluggishness of metabolic 
activation. The PDH complex exists in two forms: an inactive phosphorylated form and an active 
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dephosphorylated form, with its activity at any instance determined by the relative 
phosphorylation state. The covalent regulation of PDH activity is determined by the relative 
activities of two regulatory enzymes, PDH kinase (PDK) and PDH phosphatase (PDP). Up 
regulation of PDK results in phosphorylation and inhibition of the PDH complex (specifically, 
phosphorylation of the E1 enzyme), while up regulation of PDP leads to dephosphorylation and 
activation of the PDH complex. The activity of PDK is increased by higher: ATP/ADP, 
NADH/NAD+, and Acetyl CoA/CoA ratios. It is inhibited by increased intracellular pyruvate and 
sarcoplasmic Ca2+ levels. Increased Ca2+ levels activate PDP (60). Specifically, as Ca2+, ADP, 
and pyruvate levels increase with exercise intensity PDH activity increases. 
Pharmacological up-regulation of PDH prior to exercise has been used to investigate the 
importance of PDH with respect to the rate of adjustment of 2OV& (29, 37, 55). Dichloroacetate 
(DCA) is a drug commonly used to experimentally activate PDH through the inhibition of PDK. 
Howlett et. al. found that DCA reduced the contribution of substrate-level phosphorylation (as 
measured by lower lactate accumulation) to energy production during exercise at 65% 2OV& peak 
(29). This group also saw a reduction in glycogenolysis and inorganic phosphate (Pi) 
accumulation after 10 minutes of exercise. These results suggested faster activation of oxidative 
metabolism when PDH activation was increased. Investigations that have measured the effect of 
DCA administration on 2OV& have not shown a decrease in τ 2pOV&
 
within the moderate (37), or 
heavy intensity domains (55) in vivo. These DCA studies have shown an effect of increased 
PDH activity on oxidative metabolism but that effect has not been powerful enough to argue that 
PDH activity limits τ 2pOV& .  
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Dietary manipulation has been shown to have a direct effect on PDH activity at rest. 
Peters et al. reported a decrease in PDH activity at rest while on a low carbohydrate (LCHO) diet 
which was attributed to elevated PDK activity (50). A follow-up study by the same group 
showed that PDH responds to dietary manipulation within one day of dietary manipulation (49). 
An investigation by St. Amand et. al. observed subjects undergoing a LCHO diet and found that 
at rest PDH activity was depressed but during exercise at 65% 2OV& peak, intracellular muscle 
pyruvate content inhibited PDK and PDH activity was similar during exercise on a mixed and 
LCHO diet (61). 
Few investigations have measured the effect of the combination of dietary manipulation 
and muscle glycogen depletion (GD) on τ 2pOV&  during exercise. Raper et. al. measured the 
effects of a dietary manipulation and GD protocol on 2pOV&  in the moderate domain. They found 
that τ 2pOV&  was increased in the LCHO condition (indicating slower 2pOV&  kinetics) (53). Lima-
Silva et. al. measured 2pOV&  after GD and dietary manipulation in the heavy intensity domain and 
found increased τ 2pOV&  in the LCHO condition (43). These investigations speculate that through 
the combination of dietary manipulation and GD the effects on PDH are persistent even during 
exercise. 
Dietary manipulation may also have effects on O2 delivery. Raper also measured near-
infrared-spectroscopy (NIRS) in their investigation. NIRS provides a measure of the amount of 
O2 bound to haemoglobin (Hb) in the area of interrogation. In this regard, the relative 
concentrations of bound (oxygenated) and unbound (deoxygenated) Hb can be used to monitor 
phenomena related to O2 delivery and O2 extraction at the microvascular level. Specifically, 
deoxygenation ([HHb]) kinetics can be used as a proxy for microvascular PO2 (12). By 
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comparing the adjustment profile of 2pOV&  with [HHb] the ratio of O2 extraction to O2 
consumption may be discerned. Raper found that the time constant for [HHb] (τ[HHb])  in the 
LCHO and HCHO condition was the same despite differences in τ 2pOV& . This suggests a slowing 
in microvascular blood flow in the LCHO condition that must be compensated for through 
increased O2 extraction.  
The purpose of the current investigation was to examine the effects of low and high 
carbohydrate (HCHO) diets in combination with GD on the adjustment of 2pOV&  and [HHb] in 
subjects when transitioning from light- to heavy intensity exercise. Dietary intervention and GD 
were administered in order to manipulate substrate availability and enzyme activity (PDH). The 
hypotheses being tested were that 1) subjects will display greater phase II τ 2pOV&  values in the 
LCHO condition; 2) dietary manipulation would not have an effect on the rate of microvascular 
blood flow adjustment as indicated by similar [HHb] kinetics. 
2.2 Methods 
Participants: Healthy male subjects (n, 10; age, 24 ± 3 yrs); 2OV& peak (3.94 ± 0.47 L/min), 
volunteered to participate in the study. All subjects were recreationally active, non-smokers, and 
had no known history of respiratory, cardiovascular, metabolic or musculoskeletal disease and 
were not taking medications that might have affected the physiological variables under 
investigation. Subjects were informed of the protocol, and possible risks and discomforts 
associated with the procedure, both verbally and in writing, before starting data collection.  
Subjects gave written, informed consent prior to their voluntary participation in the study. All 
procedures were approved by The University of Western Ontario Health Sciences Research 
Ethics Board. 
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Preliminary testing: Subjects reported to the laboratory for a ramp incremental exercise 
test (25w/min) to volitional fatigue on an electrically-braked cycle ergometer (H-300-R Lode; 
Lode BV) for determination of 2pOV& peak and estimated Lθˆ . The values obtained from this test 
were used to determine a WR within the heavy-intensity domain of exercise which corresponded 
to ~ 35% of the difference between the 2pOV&  at the Lθˆ  and 2OV& peak (i.e. ∆35). The Lθˆ  was 
estimated using standard ventilatory and gas exchange indices (25). It was defined as the 2pOV&  
at which 1) pulmonary CO2 output ( 2pCOV& ) began to increase out of proportion to the increase 
in 2pOV&  and 2) there was a systematic rise in the ventilatory equivalent for 2pOV&  ( EV& / 2pOV& ) 
and end-tidal PO2 (PETO2) without a systematic rise in the ventilatory equivalent for 2pCOV&  ( EV&
/ 2pCOV& ) and PETCO2.  
Subjects submitted a two-day diet record (one weekday, one weekend day) which was 
used to analyze their “normal” mixed diet composition and to estimate their daily caloric intake.  
Food records were analyzed using Diet Analysis 9.0 software. This program was also used to 
design individualized LCHO and HCHO diets that were used as the dietary intervention for this 
study; diets were eucaloric relative to their “normal” mixed diet submitted in the food records. 
The LCHO diet was aimed to contain 10%, 70%, and 20% of carbohydrates, fat, and protein 
respectively. The HCHO diet was aimed to contain 80%, 10%, and 10% of carbohydrates, fat, 
and protein respectively. Similar diets have been shown in the past to affect PDH activity (38). 
Glycogen depletion and dietary intervention: A GD protocol was completed by subjects 
on their second visit to the laboratory. The protocol consisted of 60 min cycle ergometer exercise 
at an intensity equivalent to 70% 2OV& peak, which was followed immediately by 5 repeated 
cycling bouts at a WR corresponding to 110% of the peak WR achieved during the initial 
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incremental exercise test. Each cycling interval bout lasted 1 min and was separated by 4 min of 
loadless cycling. Variations of this protocol have previously lowered muscle glycogen content by 
55-90% (11). 
Following the GD protocol subjects began the LCHO diet. Each dietary phase lasted four 
days. On day three of the diet subjects performed two step-transitions to ∆35 exercise, with each 
separated by at least 1 hour of resting recovery. The ∆35 constant-load exercise test began with 
six minute baseline cycling at 20 W, followed by a step-increase to a WR corresponding to ∆35 
which lasted eight minutes. During these exercise tests pulmonary gas exchange was measured 
breath-by-breath and local muscle [HHb] was measured continuously in the vastus lateralis 
muscle of the quadriceps muscle group using NIRS. Subjects were instructed to refrain from 
strenuous exercise in the preceding 24 hours before a test. On day four of the diets subjects 
performed a ∆35 exercise bout with the collection of muscle biopsies. During the biopsy rides 
subjects had muscle biopsies taken from the vastus lateralis muscle during cycling at three time 
points: during 6 minute baseline 20W cycling, 15 s after the onset of ∆35 exercise, and 8 minutes 
after the step transition. Biopsies were frozen in liquid nitrogen for later analysis of: glycogen 
content, ADP concentration, Pcr concentration, and PDH activation. 
Following the biopsies on day four of the LCHO diet the GD protocol was repeated. 
After the second GD protocol a HCHO diet was followed and measurements were repeated in 
the same timeframes as in the LCHO condition. The order of the diets were not randomized 
because this order of LCHO followed by HCHO diet, with each preceded by a glycogen 
depletion protocol, has been shown to significantly lower and then maximize muscle glycogen 
levels (7). All food was purchased and provided to the subjects along with strict meal plans. If 
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any portion of the prescribed diet was not consumed, this portion was weighed to establish the 
exact caloric intake for each subject during each of the dietary phases. 
Measurements: Pulmonary gas-exchange measurements were similar to those previously 
described (57). Briefly, inspired and expired flow rates were measured using a low dead space 
bidirectional turbine (Alpha Technologies VMM 110) which was calibrated before each test 
using a 3L syringe. Inspired and expired gases were sampled continuously (50Hz) at the mouth 
and analyzed for concentrations of O2, CO2, and N2 by mass spectrometry (Innovision, Amis 
2000, Lindvedvej, Denmark) after calibration with precision-analyzed gas mixtures. Changes in 
fractional gas concentrations were aligned with inspired and expired gas volumes by measuring 
the time delay (TD) for a square-wave bolus of gas to travel from the turbine transducers along a 
capillary sample line to the mass spectrometer. Data were transferred to a computer, which 
aligned concentrations with volume information to build a profile of each breath. Breath-by-
breath alveolar gas exchange was calculated using the algorithms of Beaver et. al. (4).  
Heart rate (HR) was monitored continuously by three-lead electrocardiogram (ECG) 
using PowerLab (ML132/ML880; ADInstruments, Colorado Springs, CO); HR was calculated 
based upon the R-R interval and was reported on a second–by-second basis. Data were recorded 
on a separate data collection computer using LabChart v6.1. 
Local muscle [HHb] of the quadriceps vastus lateralis muscle was monitored 
continuously with a frequency-domain multi-distance NIRS system (Oxiplex TS, Model 95205, 
ISS, Champaign, IL, USA) as described elsewhere (58). The NIRS probe was placed on the belly 
of the muscle, midway between the lateral epicondyle and greater trochanter of the femur; it was 
secured in place with an elastic strap tightened to prevent movement and covered with an 
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optically-dense, black vinyl sheet, thus minimizing the intrusion of extraneous light and loss of 
NIR light. NIRS measurements were collected continuously for the entire duration of each trial. 
Briefly, the system was comprised of a single channel consisting of eight laser diodes operating 
at two wavelengths (λ = 690 and 828 nm, four at each wavelength) which were pulsed in a rapid 
succession (110 MHz) and a photomultiplier tube. The lightweight plastic NIRS probe 
(connected to laser diodes and photomultiplier tube by optical fibers) consisted of two parallel 
rows of light emitter fibers and one detector fiber bundle; the source-detector separations for this 
probe were 2.0, 2.5, 3.0, and 3.5 cm for both wavelengths. 
The NIRS system was calibrated at the beginning of each testing session following an 
instrument warm-up period of at least 20 minutes. Calculation of [HHb] reflected continuous 
measurements of a reduced scattering coefficient (µs’) made throughout each testing session (i.e., 
constant scattering value not assumed). Data were stored online at an output frequency of 25 Hz, 
but were reduced to 1 s bins for all subsequent analyses within the present study.  
Data Analysis: Gas exchange data were edited by removing aberrant data points that lay 
outside four standard deviations (SD) of the local mean. The data for each transition were 
linearly interpolated to 1 s intervals and time-aligned such that time zero represented the onset of 
exercise. Data from both ∆35 transitions were ensemble-averaged to yield a single, averaged 
response for each subject. This transition was further time-averaged into 5 s bins to provide a 
single time-averaged response for each subject. The phase I-phase II transition was identified as 
previously described . The on-transient response for 2pOV&  was modeled using the following 
equation: 
Y(t) =Ybsln+Amp[1-e-(t-TD)/τ]                                                                                            Eq.1 
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Where Y(t) represents 2pOV&  at any time; Ybsln is the average 2pOV& ss measured during the 
period immediately before the change in WR; Amp (amplitude) is the steady-state increase in 
2pOV&  above the baseline 2pOV& ( 2pOV& bsl) ; τ represents the time required to attain 63% of the 
steady-state amplitude; and TD is mathematically generated as the point at which the exponential 
model is predicted to intersect the baseline. Steady-state 2pOV& bsl was established from data 60 s 
before the change in WR. Data were modeled from the phase I-phase II transition to the onset of 
the slow component (determined in a similar fashion to the phase I-phase II transition (25)) using 
Origin data fitting software (OriginLab). The 95% confidence interval for the estimated τ was 
determined following a preliminary fit with Ybsln, Amp, and TD constrained to best fit values, 
with the τ allowed to vary. The slow component was modelled using a linear equation over the 
last 30 s of exercise. End exercise 2pOV&  was measured as the average of the last 15 s of exercise. 
The NIRS-derived [HHb] data were time-aligned and ensemble-averaged to 5 s bins to 
yield a single response for each subject. The [HHb] profile has been described to consist of a 
time delay at the onset of exercise followed by an “exponential-like” increase in the signal 
towards a new steady-state exercise value (15). The TD for the [HHb] response was estimated 
for each subject using second-by-second data and corresponded to the time after the onset of 
exercise where the [HHb] signal showed a consistent increase above the nadir value, as described 
previously (24). The [HHb] data were modeled from the end of the TD-HHb to 90 s using a 
monoexponential function of the form in Eq. 1 to determine τ[HHb]. This model was chosen 
because it offered the best consistent fits for the transition. Baseline [HHb] was determined for 
each trial as the mean value in the 60 s before a transition. Mean response time (MRT= [HHb]TD 
+ τ[HHb]) was calculated to describe the overall time course for muscle [HHb]. End-exercise 
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data was calculated as the average of the last 30 s of exercise. The steady-state value for [HHb] 
was determined as the end point for the fitting of the monoexponential function ([HHb]ss). 
The second-by-second [HHb] and 2pOV&  data were normalized for each subject (0%, 
representing the 20 W baseline value, and 100%, representing the phase II value). The 
normalized phase II 2pOV&
 
were then modeled using the parameter values for individual subjects. 
The normalized adjustment of muscle O2 utilization was shifted toward the start of each step 
transition by a time corresponding to the estimated phase II TD for each transition, thereby 
making the normalized 2pOV&  at the immediate onset of the transition equal to “zero”. [HHb] data 
was not modeled; it was derived from the raw second-by-second signal. An [HHb]/ 2pOV&  ratio 
was calculated with a value of 1.0 corresponding to a match between [HHb] and 2pOV& . An 
overshoot in the [HHb]/ 2pOV&  response profile was estimated by integrating the area bounded by 
the [HHb]/ 2pOV&  profile and a ratio value equal to 1.0. The start point was selected to be 20 s to 
begin the analysis. During the adjustment within the initial ~20 s, the blood flow response and O2 
delivery is adequate to sustain early increases in 2pOV&  and therefore, the [HHb]/ 2pOV&
 
as 
described was not used to attempt to characterize this period of the response. The end point of 
the analysis was selected to be 120 s, meant to reflect the time point at which the [HHb]/ 2pOV&  
ratio reached a steady-state of 1.0 in all subjects.  
The on-transient HR response was modeled from the onset of exercise to the end of phase 
II of 2pOV&  using Eq. 1. This strategy offered the best consistent fits for the transition. HRbsl was 
calculated from the last 30 s of 20 W exercise. End exercise HR was calculated from the last 30 s 
of the entire HR response. 
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Statistics: Statistical analyses were performed using SPSS 20. Differences between 
HCHO and LCHO diets with respect to parameter estimates of: 2OV& , HR, and [HHb] were 
analyzed using repeated measured ANOVA (diet condition as main effect). Statistical 
significance was accepted at p<0.05. All data are presented as mean ± SD. 
2.3 Results 
 Physical characteristics of the subjects and aerobic parameters measured during the ramp 
incremental exercise test are presented in Table 1. Subjects were able to complete the entire 
glycogen depletion protocol prior to the LCHO diet. None of the subjects were able to complete 
the full one hour of cycling at 70% 2OV& peak before the HCHO diet (35 minutes ± 5 minutes), all 
were able to complete the five one-minute sprint interval component of the glycogen depletion 
protocol before the HCHO diet. 
Diets had an average daily caloric intake of 2810 ± 324, 2834 ± 318, and 2791 ± 308 kcal 
for mixed, LCHO, and HCHO respectively. The relative carbohydrate, fat, and protein content of 
the diets consumed during the study were, respectively: 10% ± 2, 64% ± 3, and 27% ± 4 for the 
LCHO, and 76% ± 3, 11% ± 2, and 16% ± 2 for the HCHO. 
As expected, the WRs used in the present study represented an intensity within the heavy 
domain of exercise as evidenced by an end-exercise 2pOV&  that was greater than the 2pOV&  at Lθˆ
and a 2pOV& profile which exhibited a visually identifiable 2pOV&  slow component in 9 of 10 
subjects.   
The group mean response profile for the calculated respiratory exchange ratio (RER= 
2pCOV& / 2pOV& ) for the LCHO and HCHO conditions is presented in Figure 1.  The calculated 
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RER during steady-state baseline cycling at 20 W was significantly higher (p < 0.05) in the 
HCHO (0.97 ± 0.18) compared to the LCHO (0.8 ± 0.07) diet; RER remained elevated in 
HCHCO compared to LCHO throughout the transition to ∆35 exercise (Figure 1). This data is 
indicative of a lesser oxidation of CHO in the LCHO condition compared to the HCHO 
condition. 
The group mean response for 2pCOV&  is presented in Figure 2. 2pCOV&  was significantly 
lower (p<0.05) in the LCHO (0.79±0.16) condition compared with the HCHO (0.90±0.19) 
condition during baseline 20 W exercise. 
  The group means response profile for 2pOV&  in the LCHO and HCHO conditions is 
presented in Figure 3A, while the 2pOV&  response profile for a representative subject during the 
HCHO condition, along with the model-derived line-of-best fit and residuals (difference between 
actual data and the model-derived line-of-best fit) is presented in Figure 3B. The summary of the 
parameter estimates for the 2pOV&  kinetics response for the dietary conditions is presented in 
Table 2. Statistical analysis showed that all variables with the exception of 2pOV&  baseline, slow 
component amplitude, and TD were significantly greater in the LCHO condition (p<0.05) 
including: amplitude, phase II 2pOV& , τ 2pOV& , end-exercise 2pOV& , and 2pOV& gain ( 2pOV& gain= ∆
2pOV& /∆WR) (p<0.05). 2pOV& bsl and slow component amplitude were not statistically different 
(p>0.05). TD was significantly greater in the HCHO condition (p<0.05). Figure 4 illustrates the 
individual τ 2pOV&  for each subject in the LCHO and HCHO diet, along with the group mean 
values for each diet; the τ 2pOV&  was greater in LCHO than in HCHO in 9 of the 10 subjects.  
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 Parameter estimates for the [HHb] response kinetics for transitions to ∆35 during the 
LCHO and HCHO conditions are presented in Table 3. The group means response profile for 
[HHb] for LCHO and HCHO conditions is presented in Figure 5A, while the [HHb] response 
profile for a representative subject along with the model-derived line-of-best fit and residuals 
during the HCHO condition is presented in Figure 5B.  Baseline [HHb] was the only parameter 
which showed a significant difference between LCHO (24.55 ±SD µM) and HCHO (21.73 ±SD 
µM) diets (p<0.05). Parametes of [HHb] for amplitude, steady state, τ[HHb], TD, MRT, and end-
exercise were not statistically significant (p<0.05) between conditions.  
The [HHb]/ 2pOV&
 
ratio for the LCHO and HCHO diets are presented in Figure 6A and B 
respectively. The [HHb]/ 2pOV&  ratio displayed a greater overshoot in the LCHO (1.27) condition 
compared to the HCHO (1.09) condition (p<0.05). All subjects displayed an overshoot across 
both conditions. 
The parameter estimates for HR kinetics during the transition to heavy-intensity exercise 
are presented in Table 4. Parameters of baseline, τHR, and end-exercise were not statistically 
significant (p>0.05). Amplitude of the HR response was greater (p<0.05) in the LCHO 
(63.4±10.4) condition then that HCHO (57.9±12.1) condition. Group mean HR data is presented 
in Figure 7a while data for a representative subject along with the model-derived line-of-best fit 
and residuals during the HCHO condition is presented in Figure 7b. 
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Table 1. Physical characteristics and response to ramp incremental test 
Age  
(yr) 
Body 
mass  
(kg) 
Height 
(cm) 
2pOV& peak 
(L/min) 
2pOV& peak 
(ml/kg/min) 
2pOV&  at 
Lθˆ
  
(L/min)
  
 
Estimated
2pOV&  at 
∆ 35  
(L/min) 
WR at ∆ 
35 (W) 
24 ± 3 81 ± 12 177 ± 5 3.9 ± 0.5 33.1 ± 21.9 2.2 ± 0.3 2.8 ± 0.4 204 ± 31 
Values are expressed as mean ± SD. 2pOV& peak, peak oxygen uptake; Lθˆ , estimated lactate 
threshold; ∆ 35, 35%delta; WR, work rate. 
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Table 2. Summary of parameter estimates for VO2p on-transients to heavy-intensity exercise 
during the low carbohydrate (LCHO) and high carbohydrate (HCHO) diets. 
 LCHO diet HCHO diet 
2pOV&  Baseline (L/min) 1.0 ± 0.1 0.9 ± 0.2 
2pOV&  Amplitude (L/min) 1.9 ± 0.4 1.7 ± 0.4* 
End-exercise 2pOV&  (L/min) 3.2 ± 0.5 3 ± 0.5* 
Phase II 2pOV&  (L/min) 2.8 ± 0.4 2.6 ± 0.4* 
Phase II τVO2p (s) 41.9 ± 11.5 33.9 ± 7.3* 
2pOV&  TD (s) 1.6 ± 7.8 9 ± 7.2* 
Phase II VO2p  gain 
(ml/min/W) 
10.1 ± 1.1 9.4 ± 1.3* 
2pOV&  Ampsc (L) 0.3 ± 0.1 0.3 ± 0.1 
95% CI (s) 5.5 ± 2.1 3.9 ± 1.5 
Values are expressed as means ± SD. τVO2p, time constant for phase II VO2p; TD, time delay; 
VO2p gain, ∆VO2p/∆WR; Ampsc, slow component amplitude; CI, confidence interval for phase II 
τ 2pOV& . 
*Significant difference (P<0.05) between the LCHO and HCHO diets. 
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Table 3. Parameter estimates for NIRS-derived deoxygenation concentration [HHb] changes 
during the transition to heavy-intensity exercise in the LCHO and HCHO diets 
 LCHO HCHO 
[HHb] baseline (µM) 24.6 ± 6.4 21.7 ± 5.5* 
[HHb] amplitude (µM) 12.5 ± 6.7 9.9 ± 3.6 
[HHb] steady state (µM) 37 ± 12.7 31.6 ± 8.6 
τ[HHB]  (s) 12.9 ± 3.4 10.6 ± 1.9 
CTD [HHb] (s) 5.8 ± 2.6 5.7 ± 1.8 
MRT (s) 18.7 ± 3.4 16.3 ± 2.1 
95% CI (s) 2.3 ± 0.8 2.5 ± 1.5 
End exercise (µM) 39.1 ± 12.8 34.2 ± 9.1 
Values are expressed as means ± SD.τ[HHb], time constant for the adjustment of [HHb]; CTD 
[HHb], calculated time delay for [HHb]; MRT, mean response time; CI, confidence interval for 
τ[HHb]. 
*Significant difference (P<0.05) between LCHO and HCHO diets 
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Table 4. Parameter estimates for heart rate (HR) kinetics during the transition to heavy-intensity 
exercise in the LCHO and HCHO diets. 
 LCHO HCHO 
Baseline HR (beats/min) 89 ± 12.2 91.8 ± 7.9 
HR Amplitude (beats/min) 63.4 ± 10.4 57.9 ± 12.1* 
τHR (s) 42.3 ± 23.5 39.9 ± 14.6 
End exercise HR (beats/min) 166.3 ± 13.9 160.1 ± 12.3 
95% CI (s) 7.3 ± 8.6 7.45 ± 7.5 
 
Values are expressed as means ± SD. τHR, time constant for HR adjustment; CI, confidence 
interval for τHR. 
*Significant difference (P<0.05) between the LCHO and HCHO diets 
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Figure 1. Group mean respiratory exchange ratio (RER=VCO2/VO2) response during baseline 
and heavy-intensity exercise; open circles, LCHO diet; closed circles, HCHO diet. Dashed line 
represents the onset of step-change in WR. 
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Figure 2. Second-by-second group mean VCO2 response during the transition to heavy-intensity 
exercise; open circles, LCHO diet; closed circles, HCHO diet. Dashed line represents the onset 
of the step-change in WR. 
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Figure 3a. Second-by-second group mean VO2 response during the transition to heavy-intensity 
exercise; open circles, LCHO diet; closed circles, HCHO diet. Dashed line represents the onset 
of the step-change in WR.  
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Figure 3b. Second-by-second VO2p response for a representative subject during the transition to 
heavy-intensity exercise in the HCHO condition. Red lines represent the modelled line of best fit. 
Black lines represent residuals. Dashed line represents the onset of the step-change in WR. 
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Figure 4. Individual and group mean VO2 time constants (τVO2) for the LCHO and HCHO diets. 
Dotted lines connect individual data. Solid line connects group mean data. 
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Figure 5a. The group mean [HHb] response during the transition to heavy-intensity exercise; 
open circles, LCHO diet; closed circles, HCHO diet. Dashed line represents onset of the step-
change in WR. 
 
 
 
 
 
 
 
 36 
 
 
-120 -60 0 60 120 180 240 300 360 420 480
-4-202
420
22
24
26
28
30
32
34
36
38
40
42
44
[H
H
b] 
(µM
)
Time (s)
Figure 5b. The [HHb] response during the transition to heavy-intensity exercise in a 
representative subject during the HCHO condition. Red line represents the modelled line of best 
fit. Black line represents the residuals. Dashed line represents the onset of the step-change in 
WR. 
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Figure 6a. Group mean profiles for the relative adjustment of [HHb]/ 2pOV&  in the initial 120 s of 
heavy intensity exercise transitions, shown in the LCHO condition. 
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Figure 6b. Group mean profiles for the relative adjustment of [HHb]/ 2pOV&  in the initial 120 s of 
heavy intensity exercise transitions, shown in the HCHO condition. 
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Figure 7a. Group mean beat-by-beat mean heart rate (HR) response during the transition to 
heavy-intensity exercise; open circles, LCHO diet; closed circles, HCHO diet. Dashed line 
represents the onset of the step-change in WR. 
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Figure 7b. Beat-by-beat heart rate (HR) response during the transition to heavy-intensity exercise 
in a representative subject in the HCHO condition. Red line represents the modelled line of best 
fit. Black line represent the residuals. Dashed line represents the onset of the step-change in WR. 
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2.4 Discussion 
 This study examined 2pOV&  and muscle [HHb] kinetics during transitions to heavy-
intensity exercise during LCHO and HCHO dietary interventions combined with a GD protocol 
in an attempt to manipulate muscle substrate availability and the level of PDH activation. The 
major findings of this study were as follows: 1)  the kinetics of  2pOV&  during the transition to 
heavy-intensity exercise were slower during the LCHO condition (greater τ 2pOV&  ) compared to 
the HCHO condition, suggesting that the activation of muscle oxidative phosporylation was 
slowed on the LCHO diet; 2) despite slower 2pOV&  kinetics in the LCHO condition, the 
adjustment of [HHb] was not different between diets, suggesting that the adjustment of muscle 
microvascular blood flow was attenuated in the LCHO condition compared to the HCHO 
condition. 
It appears that the dietary manipulation and GD protocol that was administered was 
effective in influencing substrate availability and utilization. Although muscle glycogen data was 
not available at the time of writing, previous studies using a similar GD and dietary intervention 
observed a 55-90% decrease in glycogen levels following GD (11). In addition, the resting RER 
data are significantly (p<0.05) different between conditions. This suggests differences in 
substrate utilization. The combined GD and dietary manipulation protocol was effective in 
altering 2pOV&  kinetics as demonstrated by the greater τ 2pOV&  in LCHO diet compared to the 
HCHO diet. This is in agreement with Lima-Silva et. al.. They measured 2pOV&
 
in subjects 
exercising at ∆75 until exhaustion after consuming a LCHO diet for 48 hours and completing a 
GD protocol (43). They observed a much greater τ 2pOV&  in the LCHO condition compared to the 
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HCHO condition (33 vs. 48 s). Raper et. al. also observed increased τ 2pOV&  after dietary 
manipulation and GD in the LCHO condition during moderate exercise (40s vs. 32 s) (53).  
Slowed 2pOV&  kinetics reflect a slower adjustment of oxidative metabolism at the onset of 
exercise. This slowed adjustment could be caused by limitations in O2 delivery or the inadequate 
provision of substrate for the ETC through the activity of rate-limiting metabolic enzymes. As 
PDH controls the entry of carbohydrate derived substrate into the TCAC and eventually the ETC 
it plays a large role in the initiation of oxidative metabolism. Fat metabolism is not activated as 
quickly as CHO metabolism at the onset of exercise. The ability to quickly utilize CHO-derived 
substrate allows for a faster adjustment to the step-transition in WR.  
It is reasonable to assume that the intervention in the present study altered PDH activity. 
Peters et. al. investigated the effect of dietary manipulation on PDK activity and found that PDK 
was elevated during a high fat diet (50). St. Amand et. al. and Constantin-Teodosiu et. al. also 
reported reduced PDH activity at rest following a LCHO diet (13, 61). The LCHO diets in these 
and the present study potentially cause increased rates of beta-oxidation which increased the 
levels of NADH within the cell (62). LCHO diets also lead to reduced intracellular pyruvate. 
These changes lead to a greater activation of PDK and therefore reduced PDH activity (49, 50, 
64). Dietary manipulation in the absence of GD has not been shown in the past to alter PDH 
activity during exercise. In St. Amand et. al. and Constantin-Teodosiu et. al. PDH activity in 
subjects during the LCHO condition was shown to match that of mixed diet subjects at exercise 
(13, 61). During exercise pyruvate levels in the cell increase which leads to the deactivation of 
PDK and the activation of PDH. In our investigation this may not have occurred in the LCHO 
condition as GD could have led to reduced intracellular pyruvate levels and PDH activity during 
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exercise. In the HCHO condition pyruvate levels were potentially restored after depletion which 
could have led to elevated PDH activity. 
Muscle biopsy samples were not analyzed at the time of writing. It is expected that 
biopsy data will confirm a number of ideas speculated upon in this paper. The LCHO condition 
will presumably show: lower muscle glycogen content, greater phosphocreatine breakdown, a 
higher Pi content, a lower lactate level, a greater estimated ADP, and reduced PDH activation 
throughout exercise. A lower rate of PDH activation at 15 s is also expected to be shown in the 
LCHO condition. These results would mirror the changes seen by Putman et. al. during a similar 
investigation (52). These changes are reflective of a slower rate of muscle oxidative 
phosphorylation, consistent with a slower rate of activation of PDH as well as a reduced rate of 
O2 delivery. 
The NIRS-derived [HHb] data provides insight into what effects the dietary manipulation 
had on O2 delivery. In the present study, despite a significant difference in cellular O2 demand 
(evidenced by differences in τ 2pOV& ) there was no significant difference in τ[HHb] between 
conditions suggesting that the local microvascular blood flow response was attenuated in the 
LCHO condition. This also was evident in the higher [HHb]/VO2 ratio in the LCHO diet. This 
indicates a slower adjustment of microvascular blood flow and a greater reliance on O2 
extraction from the microvasculature in the LCHO condition. Studies have shown that 
consumption of a HFAT meal leads to impaired endothelial dependent vasodilation (EDV) 
through a number of mechanisms including: eNOS inhibition, insulin resistance, and increased 
oxidative stress (18, 36, 56). These findings agree with the present data, however exercise has 
been reported to counteract the effects of a HFAT meal through anti-oxidant production and 
increased shear stress (47). Padilla et. al. measured EDV after a high fat meal at rest and during 
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exercise (47). They found that after a high fat meal and exercise EDV was greater than after a 
mixed meal without exercise. This investigation studied humans exercising for 45 minutes one 
hour prior to the measurement of EDV. Our investigation did not display an exercise effect on 
restoring blood flow following the ingestion of high fat meals. There are a few reasons for the 
apparent discrepancy in our results. 1) The timing of their measurement was different as their 
investigation was concerned with the effect on EDV one hour following exercise (it has been 
shown that endothelial function increases maximally one hour after exercise (26)). The present 
investigation was interested in measuring the effects of a HFAT diet on blood flow during the 
initial minute of exercise. 2) The longer duration of the exercise in Padilla’s investigation would 
also lead to more prolonged sheer stress and anti-oxidant production. 3) Lastly, our fat feeding 
was prolonged instead of a single meal (47).  
2.5 Conclusion 
A 4-day dietary manipulation and GD protocol was effective in influencing substrate 
utilization and τ 2pOV&  during heavy intensity exercise. During the LCHO condition τ 2pOV&  was 
significantly higher (p<0.05). It is suggested that two factors contributed to the slower 
adjustment of 2pOV&  to exercise in the LCHO condition: 1) a reduced activation of PDH, 2) a 
slower adjustment of microvascular blood flow. This study provides evidence of PDH’s 
important role in determining the speed of adjustment of 2pOV&  to exercise. It is also suggests a 
potential contribution of reduced O2 delivery to an increase in τ 2pOV&  during exercise on a 
LCHO diet.  
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2.6 Future directions and limitations 
The direct measure of conduit artery blood flow and administration of Doppler ultrasound 
for the assessment of endothelial dependent vasodilation would assist in making more conclusive 
statements on the effect of the current protocol on blood flow adjustments. Near-infrared 
spectroscopy is a useful tool but does not provide the certainty of the measures above. 
 Therefore, future research would further the present study if it gathered information on 
blood flow through conduit artery measurements or the use of Doppler ultrasonography.  
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